Say Hello!
Don’t be shy.

   

Haemostatix

Haemostatix

Home > Investment> Haemostatix

Haemostatix developed a number of haemostatic products including their lead product PeprostatTM, a topical haemostat for the treatment of bleeding during surgery. Hemostatix is now a wholly own subsidiary of Ergomed following the acquisition in May 2016.